Abstract
Pediatric Blood & CancerVolume 67, Issue 11 e28380 CORRIGENDUMFree Access Corrigendum This article corrects the following: Using CD19 chimeric antigen receptor-T cell therapy in a 4-month-old patient with infantile acute lymphoblastic leukemia David C. Shyr, Amy A. Homsombath, Priya P. Chan, Michael W. Boyer, Andrew C. Harris, Volume 67Issue 4Pediatric Blood & Cancer First Published online: January 11, 2020 First published: 22 August 2020 https://doi.org/10.1002/pbc.28380AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat In the article by David C. Shyr et al.,1 the authors wish to add some text in the acknowledgement section: The amended acknowledgement section is as follows: Close collaboration between Novartis Apheresis Operations, which included a medical science liaison, strategic account manager, and medical director, and the treatment center, which included medical team, apheresis team, and stem cell lab, helped ensure successful and safe cell collection. Early communication prior to collection significantly helped in terms of planning and minimizing the number of days until collection and the duration of temporary pheresis catheter, which is especially important in these young infants. We acknowledge that medical writing support was provided by Ina Nikolaeva, PhD, of Healthcare Consultancy Group, and this activity was funded by Novartis Pharmaceuticals Corporation REFERENCE 1Shyr DC, Homsombath AA, Chan PP, Boyer MW, Harris AC. Using CD19 chimeric antigen receptor-T cell therapy in a 4-month-old patient with infantile acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2020; 67(4):e21855. Volume67, Issue11November 2020e28380 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
